Monitor for additional institutional exits or further deterioration in shareholder confidence. The complete exit by a major holder may signal negative private views on the company's prospects.
LGVN drugs
LGVN drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $1.81entry
- T+1 · 8d ago +11.05%α +8.68% · $2.01
- T+5 · 4d ago +37.57%α +34.97% · $2.49
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Millennium Management (Integrated Core Strategies) filed an amended Schedule 13G reporting a 0.0% stake in Longeveron Inc., down from a prior position. This indicates the fund has fully exited its passive investment in the company.
Key Financial Metrics
Key Facts
- Integrated Core Strategies (US) LLC, an affiliate of Millennium Management, filed a Schedule 13G/A reporting 0.0% beneficial ownership of Longeveron Class A Common Stock as of September 30, 2026.
- The filing shows zero shares held, compared to a prior 13G filing on August 10, 2026, indicating a complete exit from the position.
- The filing is a passive investor disclosure under Rule 13d-1(c), with the filer certifying the securities were not acquired to influence control.
Financial Impact
Millennium Management held approximately $951,778 in LGVN as of Q2 2026 (per 13F); the exit of a top institutional holder removes a significant shareholder base.
Risk Factors
- Loss of a top institutional holder could reduce liquidity and investor confidence.
- The company has a very small market cap ($6M), making it vulnerable to further selling pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-123523 |
| Document: 0001104659-26-123523-index-headers.html | 0001104659-26-123523 |
| Document: 0001104659-26-123523-index.html | 0001104659-26-123523 |
| Document: 0001104659-26-123523.txt | 0001104659-26-123523 |
Track record
22 reports on LGVN
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +44.65% at T+20 after the Sep 16, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $2.53 Now $2.14 +15.42% settles Feb 12
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $2.49 Now $2.14 −14.06% settles Feb 11
- Nov 12, 20264d ago 8-K Bearish 7/10 No price data
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $2.49 Now $2.14 +14.06% settles Feb 11
- Nov 5, 202611d ago SC 13G/A Bearish 5/10 Viewing Entry $1.81 Now $2.14 −18.23% settles Feb 4
- Nov 5, 202611d ago 8-K Neutral 2/10 Entry $1.81 Now $2.14 +18.23% settles Feb 4
- Oct 26, 202621d ago 8-K Neutral 5/10 Entry $1.73 Now $2.14 +23.70% settles Jan 25
- Oct 26, 202621d ago Press Release Mixed 6/10 Entry $1.61 Now $2.14 +33.33% settles Jan 22
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $1.50 Now $2.14 +42.67% settles Jan 12
- Sep 16, 20268w ago Press Release Bearish 7/10 Entry $2.71 Now $2.14 +21.03% settles Dec 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers